Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Medroxyprogesterone acetate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Depo-Provera 150mg/1ml inj pre-filled syringes
0703022M0BBABAB
|
Depo-Provera (Contraceptive) | Medroxyprogesterone acetate | Obstetrics, Gynaecology and Urinary-Tract Disorders | 197,894 |
|
Medroxyprogesterone 150mg/1ml inj pre-filled syringes
0703022M0AAABAB
|
Medroxyprogest acetate (Contraceptive) | Medroxyprogesterone acetate | Obstetrics, Gynaecology and Urinary-Tract Disorders | 47,707 |
|
Medroxyprogesterone 10mg tablets
0604012M0AAAEAE
|
Medroxyprogest acetate (Hormone) | Medroxyprogesterone acetate | Endocrine System | 28,114 |
|
Sayana Press 104mg/0.65ml inj pre-filled disposable devices
0703022M0BDAAAC
|
Sayana Press (Contraceptive) | Medroxyprogesterone acetate | Obstetrics, Gynaecology and Urinary-Tract Disorders | 21,369 |
|
Medroxyprogesterone 5mg tablets
0604012M0AAABAB
|
Medroxyprogest acetate (Hormone) | Medroxyprogesterone acetate | Endocrine System | 9,500 |
|
Provera 10mg tablets
0604012M0BCABAE
|
Provera (Hormone) | Medroxyprogesterone acetate | Endocrine System | 7,812 |
|
Medroxyprogesterone 2.5mg tablets
0604012M0AAAFAF
|
Medroxyprogest acetate (Hormone) | Medroxyprogesterone acetate | Endocrine System | 2,765 |
|
Provera 5mg tablets
0604012M0BCAAAB
|
Provera (Hormone) | Medroxyprogesterone acetate | Endocrine System | 2,725 |
|
Medroxyprogesterone 200mg tablets
0803020H0AAADAD
|
Medroxyprogest acetate (Cancer) | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | 1,690 |
|
Medroxyprogesterone 100mg tablets
0803020H0AAACAC
|
Medroxyprogest acetate (Cancer) | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | 1,530 |
|
Medroxyprogesterone 104mg/0.65ml inj pf disposable devices
0703022M0AAACAC
|
Medroxyprogest acetate (Contraceptive) | Medroxyprogesterone acetate | Obstetrics, Gynaecology and Urinary-Tract Disorders | 1,273 |
|
Provera 100mg tablets
0803020H0BDAAAC
|
Provera (Cancer) | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | 586 |
|
Provera 200mg tablets
0803020H0BDACAD
|
Provera (Cancer) | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | 500 |
|
Medroxyprogesterone 400mg tablets
0803020H0AAAFAF
|
Medroxyprogest acetate (Cancer) | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | 490 |
|
Provera 2.5mg tablets
0604012M0BCACAF
|
Provera (Hormone) | Medroxyprogesterone acetate | Endocrine System | 424 |
|
Depo-Provera 150mg/1ml suspension for injection vials
0703022M0BBAAAA
|
Depo-Provera (Contraceptive) | Medroxyprogesterone acetate | Obstetrics, Gynaecology and Urinary-Tract Disorders | 396 |
|
Provera 400mg tablets
0803020H0BDADAF
|
Provera (Cancer) | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | 169 |
|
Medroxyprogesterone 150mg/1ml suspension for injection vials
0703022M0AAAAAA
|
Medroxyprogest acetate (Contraceptive) | Medroxyprogesterone acetate | Obstetrics, Gynaecology and Urinary-Tract Disorders | 28 |
|
Climanor 5mg tablets
0604012M0BEAAAB
|
Climanor (Hormone) | Medroxyprogesterone acetate | Endocrine System | 1 |
|
Adgyn Medro 5mg tablets
0604012M0BDAAAB
|
Adgyn Medro (Hormone) | Medroxyprogesterone acetate | Endocrine System | No data available |
|
Farlutal 100 tablets
0803020H0BCAAAC
|
Farlutal | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Farlutal 250 tablets
0803020H0BCABAE
|
Farlutal | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Farlutal 500 suspension for injection 2.5ml vials
0803020H0BCADAB
|
Farlutal | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Farlutal 500 tablets
0803020H0BCACAG
|
Farlutal | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Medroxyprogesterone 100mg/5ml oral liquid
0803020H0AAANAN
|
Medroxyprogest acetate (Cancer) | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.